Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.
Barry Manilow has been diagnosed with lung cancer and will be postponing his January concerts. “I’m very sorry that you have to change your plans,” the “Mandy” singer wrote in a statement posted to ...
Singer-songwriter Barry Manilow announced Monday that he has lung cancer and will reschedule his January shows to undergo surgery. Manilow, 82, revealed the diagnosis Monday in a statement on ...
Giving immunotherapy earlier in the day can significantly extend patients' survival, compared to giving treatment later in the day, a new study of lung cancer shows. When you purchase through links on ...
Markiplier has officially made the leap from YouTube megastar to feature-film director with Iron Lung, his intense adaptation of the viral indie horror game. The self-funded project marks his debut as ...
After more than two years in the works, Markiplier‘s feature-film directorial debut — horror sci-fi movie “Iron Lung” — is set to open in theaters in late January 2026. Markiplier, the popular YouTube ...
Dr. Daniel J. Boffa discusses advancements in lung cancer care, including the role of minimally invasive surgical techniques and new systemic therapies. Dr. Daniel J. Boffa, professor and division ...
Cancer screenings exist to try to detect the disease in its earlier stages, and ultimately to save lives. But screenings for lung cancer—the leading cause of cancer deaths worldwide—are narrow, and ...
CHICAGO (WLS) -- Northwestern Medicine is launching a new lung health center to help detect lung cancer at earlier ages. This comes after a new study shows the cancer is impacting young women and ...
In 2024, Kara Goodwin started feeling a pain in her arm and shoulder that wouldn’t go away. She was diagnosed with bicep tendinitis and frozen shoulder. Doctors thought the resident of Brooklyn, New ...
A Bayer drug designed to target tumors driven by a rare genetic mutation now has accelerated FDA approval, providing another treatment option for certain patients with advanced cases of lung cancer.
Just a few months after Boehringer Ingelheim broke into the oncology space with the first drug that can target a rare tumor type in patients with non-small cell lung cancer (NSCLC), the FDA has given ...